Joseph Carleone - Jun 30, 2023 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Role
Director
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Stock symbol
SXT
Transactions as of
Jun 30, 2023
Transactions value $
$0
Form type
4
Date filed
7/5/2023, 04:52 PM
Previous filing
May 1, 2023
Next filing
Sep 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SXT Common Stock 17.9K Jun 30, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SXT Deferred Stock Award $0 +513 +3.04% $0.00 17.4K Jun 30, 2023 Common Stock 513 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan and Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F2 Deferred stock converts to common stock on a one-for-one basis.
F3 Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
F4 Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.